BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yao W, Wang T, Huang F. p300/CBP as a Key Nutritional Sensor for Hepatic Energy Homeostasis and Liver Fibrosis. Biomed Res Int 2018;2018:8168791. [PMID: 29862292 DOI: 10.1155/2018/8168791] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Shen F, Zhuang S. Histone Acetylation and Modifiers in Renal Fibrosis. Front Pharmacol 2022;13:760308. [PMID: 35559244 DOI: 10.3389/fphar.2022.760308] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bei J, Zhu S, Du M, Hu Z, Tang Z, Chen C, Yang K, Zhong Y, Zhu X, Li W, Hu Z. Integrative analysis of multiomics data identified acetylation as key variable of excessive energy metabolism in hyperthyroidism-induced osteoporosis rats. J Proteomics 2022;252:104451. [PMID: 34883266 DOI: 10.1016/j.jprot.2021.104451] [Reference Citation Analysis]
3 Martínez-Pinteño A, Gassó P, Prohens L, Segura AG, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M, Lafuente A, Mas S, Rodríguez N. Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data. Front Pharmacol 2021;12:729474. [PMID: 34483940 DOI: 10.3389/fphar.2021.729474] [Reference Citation Analysis]
4 Maude H, Sanchez-Cabanillas C, Cebola I. Epigenetics of Hepatic Insulin Resistance. Front Endocrinol (Lausanne) 2021;12:681356. [PMID: 34046015 DOI: 10.3389/fendo.2021.681356] [Reference Citation Analysis]
5 Claveria-Cabello A, Colyn L, Arechederra M, Urman JM, Berasain C, Avila MA, Fernandez-Barrena MG. Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? Cells 2020;9:E2321. [PMID: 33086678 DOI: 10.3390/cells9102321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Sayed AM, Hassanein EH, Salem SH, Hussein OE, Mahmoud AM. Flavonoids-mediated SIRT1 signaling activation in hepatic disorders. Life Sciences 2020;259:118173. [DOI: 10.1016/j.lfs.2020.118173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
7 Zhou F, Liu Q, Zhang L, Zhu Q, Wang S, Zhu K, Deng R, Liu Y, Yuan G, Wang X, Zhou L. Selective inhibition of CBP/p300 HAT by A-485 results in suppression of lipogenesis and hepatic gluconeogenesis. Cell Death Dis 2020;11:745. [PMID: 32917859 DOI: 10.1038/s41419-020-02960-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
8 Ghosh AK. p300 in Cardiac Development and Accelerated Cardiac Aging. Aging Dis 2020;11:916-26. [PMID: 32765954 DOI: 10.14336/AD.2020.0401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yao W, Wang T, Xia J, Li J, Yu X, Huang F. Dietary Garcinol Attenuates Hepatic Pyruvate and Triglyceride Accumulation by Inhibiting P300/CBP-Associated Factor in Mid-to-Late Pregnant Rats. J Nutr 2020;150:231-9. [PMID: 31579921 DOI: 10.1093/jn/nxz238] [Reference Citation Analysis]
10 Shi M, Deng Y, Yu H, Xu L, Shi C, Chen J, Li G, Du Y, Wang YG. Protective Effects of Oridonin on Acute Liver Injury via Impeding Posttranslational Modifications of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in the Toll-Like Receptor 4 (TLR4) Signaling Pathway. Mediators Inflamm 2019;2019:7634761. [PMID: 31611735 DOI: 10.1155/2019/7634761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li J, Wang T, Xia J, Yao W, Huang F. Enzymatic and nonenzymatic protein acetylations control glycolysis process in liver diseases. FASEB J 2019;33:11640-54. [PMID: 31370704 DOI: 10.1096/fj.201901175R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
12 Zhang X, Yang S, Chen J, Su Z. Unraveling the Regulation of Hepatic Gluconeogenesis. Front Endocrinol (Lausanne). 2018;9:802. [PMID: 30733709 DOI: 10.3389/fendo.2018.00802] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 14.0] [Reference Citation Analysis]